89bio, Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 18 rows, 18 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-11-13: Reporting owner Pontifax Management 4 G.P. (2015) Ltd. | Pontifax (China) V, L.P. | Kariv Tomer | Pontifax 5 G.P. L.P. | Pontifax (Israel) V, L.P. | Pontifax (Cayman) V, L.P. | Pontifax Late Stage GP Ltd. | Pontifax Late Stage Fund L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2019-11-13: Reporting owner Naschitz Anat; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2019-11-13: Reporting owner Naschitz Anat; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2019-11-13: Reporting owner RA Capital Healthcare Fund LP | Shah Rajeev M. | RA CAPITAL MANAGEMENT, L.P. | Kolchinsky Peter; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-11-13 | Pontifax Management 4 G.P. (2015) Ltd. | Pontifax (China) V, L.P. | Kariv Tomer | Pontifax 5 G.P. L.P. | Pontifax (Israel) V, L.P. | Pontifax (Cayman) V, L.P. | Pontifax Late Stage GP Ltd. | Pontifax Late Stage Fund L.P. 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | C Conversion of derivative security | −5,500,001 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | Naschitz Anat Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | C Conversion of derivative security | −7,944,444 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | Naschitz Anat Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | C Conversion of derivative security | −7,944,444 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | RA Capital Healthcare Fund LP | Shah Rajeev M. | RA CAPITAL MANAGEMENT, L.P. | Kolchinsky Peter Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −10,327,777 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | Grunberg Gregory Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −11,916,667 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | Hayden Michael R Director | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −366,667 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | Longitude Venture Partners III, L.P. | Tammenoms Bakker Juliet | Longitude Capital Partners III, LLC | ENRIGHT PATRICK G 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −11,916,667 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | OrbiMed Advisors Israel II Ltd | OrbiMed Capital GP VI LLC | OrbiMed Israel GP II, L.P. | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −7,944,444 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-13 | OrbiMed Advisors Israel II Ltd | OrbiMed Capital GP VI LLC | OrbiMed Israel GP II, L.P. | ORBIMED ADVISORS LLC Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −7,944,444 0 owned after | $0.00 | 2019-11-13 | |
| 2019-11-08 holding as of filing | Longitude Venture Partners III, L.P. | ENRIGHT PATRICK G | Tammenoms Bakker Juliet | Longitude Capital Partners III, LLC 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Pontifax (Cayman) V, L.P. | Pontifax Management 4 G.P. (2015) Ltd. | Pontifax (China) V, L.P. | Kariv Tomer | Pontifax 5 G.P. L.P. | Pontifax (Israel) V, L.P. 10% Owner | 10% Owner | 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | OrbiMed Israel GP II, L.P. | ORBIMED ADVISORS LLC | OrbiMed Advisors Israel II Ltd | OrbiMed Capital GP VI LLC 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | OrbiMed Israel GP II, L.P. | ORBIMED ADVISORS LLC | OrbiMed Advisors Israel II Ltd | OrbiMed Capital GP VI LLC 10% Owner | Director, 10% Owner | 10% Owner | 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Naschitz Anat Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See foonote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Naschitz Anat Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See foonote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Hayden Michael R Director | 3 | Series A Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Grunberg Gregory Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2019-11-08 | ||
| 2019-11-08 holding as of filing | Shah Rajeev M. | RA CAPITAL MANAGEMENT, L.P. | RA Capital Healthcare Fund LP | Kolchinsky Peter Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 3 | Series A Preferred Stock Derivative · Indirect · See footnote | Holding | no price filed | 2019-11-08 |